BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 16790692)

  • 21. Accelerated lymphangiogenesis in malignant lymphoma: possible role of VEGF-A and VEGF-C.
    Kadowaki I; Ichinohasama R; Harigae H; Ishizawa K; Okitsu Y; Kameoka J; Sasaki T
    Br J Haematol; 2005 Sep; 130(6):869-77. PubMed ID: 16156857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular endothelial growth factor expression in low and high grade B-cell non-Hodgkin's lymphomas.
    Ozbudak IH; Akkaya B; Karpuzoğlu G
    Turk Patoloji Derg; 2011; 27(3):204-9. PubMed ID: 21935869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of c-Myc and p53 correlates with clinical outcome in diffuse large B-cell lymphomas.
    Chang CC; Liu YC; Cleveland RP; Perkins SL
    Am J Clin Pathol; 2000 Apr; 113(4):512-8. PubMed ID: 10761452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of vascular endothelial growth factor, basic fibroblastic growth factor, and microvessel density and their relation to cell proliferation in B-cell non-Hodgkin's lymphoma.
    Alshenawy HA
    Ann Diagn Pathol; 2010 Oct; 14(5):321-7. PubMed ID: 20850693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disappearance of CD21-positive follicular dendritic cells preceding the transformation of follicular lymphoma: immunohistological study of the transformation using CD21, p53, Ki-67, and P-glycoprotein.
    Shiozawa E; Yamochi-Onizuka T; Yamochi T; Yamamoto Y; Naitoh H; Kawakami K; Nakamaki T; Tomoyasu S; Kushima M; Ota H
    Pathol Res Pract; 2003; 199(5):293-302. PubMed ID: 12908519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of interphase fluorescence in situ hybridization for the t(14;18)(q32;q21) translocation in the diagnosis of follicular lymphoma on fine-needle aspirates: a comparison with flow cytometry immunophenotyping.
    Gong Y; Caraway N; Gu J; Zaidi T; Fernandez R; Sun X; Huh YO; Katz RL
    Cancer; 2003 Dec; 99(6):385-93. PubMed ID: 14681948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma.
    Muris JJ; Meijer CJ; Vos W; van Krieken JH; Jiwa NM; Ossenkoppele GJ; Oudejans JJ
    J Pathol; 2006 Apr; 208(5):714-23. PubMed ID: 16400625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of vascular endothelial growth factor in lymphomas and Castleman's disease.
    Foss HD; Araujo I; Demel G; Klotzbach H; Hummel M; Stein H
    J Pathol; 1997 Sep; 183(1):44-50. PubMed ID: 9370946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
    Giatromanolaki A; Koukourakis MI; Kakolyris S; Turley H; O'Byrne K; Scott PA; Pezzella F; Georgoulias V; Harris AL; Gatter KC
    Clin Cancer Res; 1998 Dec; 4(12):3017-24. PubMed ID: 9865915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of VEGF and angiopoietin 2: a key to high vascularity of hepatocellular carcinoma?
    Moon WS; Rhyu KH; Kang MJ; Lee DG; Yu HC; Yeum JH; Koh GY; Tarnawski AS
    Mod Pathol; 2003 Jun; 16(6):552-7. PubMed ID: 12808060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival.
    Hawighorst H; Knapstein PG; Knopp MV; Weikel W; Brix G; Zuna I; Schönberg SO; Essig M; Vaupel P; van Kaick G
    Cancer Res; 1998 Aug; 58(16):3598-602. PubMed ID: 9721867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microarray reveals differences in both tumors and vascular specific gene expression in de novo CD5+ and CD5- diffuse large B-cell lymphomas.
    Kobayashi T; Yamaguchi M; Kim S; Morikawa J; Ogawa S; Ueno S; Suh E; Dougherty E; Shmulevich I; Shiku H; Zhang W
    Cancer Res; 2003 Jan; 63(1):60-6. PubMed ID: 12517778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma.
    Marrogi AJ; Travis WD; Welsh JA; Khan MA; Rahim H; Tazelaar H; Pairolero P; Trastek V; Jett J; Caporaso NE; Liotta LA; Harris CC
    Clin Cancer Res; 2000 Dec; 6(12):4739-44. PubMed ID: 11156228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Centroblastic and centroblastic/centrocytic lymphoma associated with a prominent epithelioid granulomatous response: a clinicopathologic study of 50 cases.
    Kojima M; Nakamura S; Ichimura K; Suzuki R; Kagami Y; Kondo E; Motoori T; Hosomura Y; Oyama T; Itoh H; Ban S; Yoshida K; Ohno Y; Shimizu K; Masawa N; Sugihara S
    Mod Pathol; 2002 Jul; 15(7):750-8. PubMed ID: 12118113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microvessel density and expression of vascular endothelial growth factor and its receptors in different subtypes of primary cutaneous B-cell lymphoma.
    Wobser M; Siedel C; Kneitz H; Bröcker EB; Goebeler M; Houben R; Geissinger E
    Acta Derm Venereol; 2013 Nov; 93(6):656-62. PubMed ID: 23624620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Correlation of angiogenesis with expression of vascular endothelial growth factor and its receptors in lung carcinoma].
    Zhang G; Zhao M; Xu M; Yang Y; Wang M; Yang C
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Feb; 25(2):89-93. PubMed ID: 11953105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma.
    Fine BA; Valente PT; Feinstein GI; Dey T
    Gynecol Oncol; 2000 Jan; 76(1):33-9. PubMed ID: 10620438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma.
    Ng IO; Poon RT; Lee JM; Fan ST; Ng M; Tso WK
    Am J Clin Pathol; 2001 Dec; 116(6):838-45. PubMed ID: 11764072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microvascular density in non-Hodgkin B-cell lymphomas measured using digital morphometry.
    Mezei T; Horváth E; Turcu M; Gurzu S; Raica M; Jung I
    Rom J Morphol Embryol; 2012; 53(1):67-71. PubMed ID: 22395502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T-cell-rich large-B-cell lymphomas contain non-activated CD8+ cytolytic T cells, show increased tumor cell apoptosis, and have lower Bcl-2 expression than diffuse large-B-cell lymphomas.
    Felgar RE; Steward KR; Cousar JB; Macon WR
    Am J Pathol; 1998 Dec; 153(6):1707-15. PubMed ID: 9846961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.